Atrieflimmer

Fibrillation

- Atrieflimmer;
http://www.emea.europa.eu/

- Atrial fibrillation;
http://www.emea.europa.eu/

Hjertestop Myokardieinfarkt Atrieflimmer Supraventrikulær takykardi Arytmi Bradykardi Abnormt EKG
http://www.emea.europa.eu/

Cardiac arrest Myocardial infarction Atrial fibrillation Supraventricular tachycardia Arrhythmia Bradycardia Abnormal ECG
http://www.emea.europa.eu/

Myokardieinfark t Atrieflimmer Supraventrikulær takykardi Arytmi Bradykardi Abnormt EKG Perifer iskæmi

Myocardial infarction Atrial fibrillation Supraventricular tachycardia Arrhythmia Bradycardia Abnormal ECG Peripheral ischaemia

Hjertestop Myokardieinfarkt Angina pectoris Atrieflimmer Arytmi, supraventirkulær Sinusbradykardi Supraventrikulære ekstrasystoler
http://www.emea.europa.eu/

Cardiac arrest Myocardial infarction Angina pectoris Atrial fibrillation Arrhythmia supraventricular Sinus bradycardia Supraventricular extrasystoles
http://www.emea.europa.eu/

Myokardie -infarkt Atrieflimmer Supraventrikulær takykardi Arytmi Bradykardi Abnormt EKG Perifer iskæmi

Myocardial infarction Atrial fibrillation Supraventricular tachycardia Arrhythmia Bradycardia Abnormal ECG Peripheral ischaemia

Angina pectoris Myocardiel iskæmi Atrieflimmer Arytmi Takykardi Sinus takykardi Palpitationer Dyb venethrombose

Angina pectoris Myocardial ischaemia Atrial fibrillation Arrhythmia Tachycardia Sinus tachycardia Palpitations Deep vein thrombosis

Ustabil angina, Angina pectoris, Myokardiel iskæmi, Atrieflimmer, Arytmi, Takykardi, Sinus takykardi, Palpitationer
http://www.emea.europa.eu/

Angina unstable, Angina pectoris, Myocardial ischaemia, Atrial fibrillation, Arrhythmia, Tachycardia, Sinus tachycardia, Palpitations
http://www.emea.europa.eu/

myokardieinfarkt (0, 5% over for 0, 2%), atrieflimmer (0, 2% over for 0%), angina pectoris (0, 3% over for 0, 2%)
http://www.emea.europa.eu/

myocardial infarction (0.5% vs 0.2%), atrial fibrillation (0.2% vs 0%), angina pectoris (0.3% vs 0.2%)
http://www.emea.europa.eu/

Hypersensitivitet Tumorlysissyndrom Hyperglykæmi Nedsat total protein AnoreksiVertigoKonjunktivit Hjertestop Myokardieinfarkt Angina pectoris Atrieflimmer Arytmi, supraventirkulær Sinusbradykardi Supraventrikulære ekstrasystoler Ortostatisk hypotension Hedeture Rødmen Hypoxi Pleural effusion Dysfoni Rinorré

Orthostatic hypotension Hot flush Flushing Hypoxia Pleural effusion Dysphonia Rhinorrhoea Ileus Oral discomfort Stomach discomfort Diarrhoea Rash pruritic

Anafylaktisk reaktion Hypersensitivitet Tumorlysesyndrom Hyperglykæmi Nedsat total protein AnoreksiVertigoKonjunktivitis Hjertestop Myokardieinfarkt Angina pectoris Atrieflimmer Arytmi, supraventirkulær Sinusbradykardi Supraventrikulære ekstrasystoler Ortostatisk hypotension Hedeture Rødmen Hypoxi Pleural effusion Dysfoni Rinorré

Orthostatic hypotension Hot flush Flushing Hypoxia Pleural effusion Dysphonia Rhinorrhoea Ileus Oral discomfort Stomach discomfort Diarrhoea Rash pruritic

De alvorlige bivirkninger, der kunne henføres til TRISENOX, inkluderede APL - differentieringssyndrom (3), leukocytose (3), forlænget QT- interval (4, 1 med torsade de pointes), atrieflimmer/ atrieflagren (1), hyperglykæmi (2) og en række forskellige alvorlige bivirkninger i relation til blødninger, infektioner, smerte, diarré, kvalme.
http://www.emea.europa.eu/

Those serious adverse reactions attributed to TRISENOX included APL differentiation syndrome (3), leukocytosis (3), prolonged QT interval (4, 1 with torsade de pointes), atrial fibrillation/ atrial flutter (1), hyperglycaemia (2) and a variety of serious adverse reactions related to haemorrhage, infections, pain, diarrhoea, nausea.
http://www.emea.europa.eu/

De alvorlige bivirkninger (AB) , der kunne henføres til TRISENOX, inkluderede APL -differentieringssyndrom (3) , leukocytose (3) , forlænget QT-interval (4, 1 med torsade de pointes) , atrieflimmer/atrieflagren (1) , hyperglykæmi (2) og en række forskellige alvorlige bivirkninger i relation til blødninger, infektioner, smerte, diarré, kvalme.

Those serious adverse reactions attributed to TRISENOX included APL differentiation syndrome (3) , leukocytosis (3) , prolonged QT interval (4, 1 with torsade de pointes) , atrial fibrillation/atrial flutter (1) , hyperglycaemia (2) and a variety of serious adverse reactions related to haemorrhage, infections, pain, diarrhoea, nausea.